Zotefoams Directors Acquire Shares
Why we think this is neutral
This RNS announcement is a notification of director share transactions, which does not fall into the mandatory news types specified. As a result, a neutral sentiment score is assigned.
Key Points
- Group CFO Gary Christopher McGrath acquired 15,948 shares at £2.3200 per share on 9 April 2025
- Group CEO Ronan Michael Cox acquired 8,008 shares at £2.4972 per share on 10 April 2025
Summary
The specialty chemicals company Zotefoams has announced that two of its directors have acquired ordinary shares in the company.
Zotefoams plc, a world leader in cellular materials technology, has announced that on 9 April 2025, the Group CFO Gary Christopher McGrath acquired 15,948 ordinary shares at a price of £2.3200 per share, and on 10 April 2025, the Group CEO Ronan Michael Cox acquired 8,008 ordinary shares at a price of £2.4972 per share.
DIRECTOR DEALINGS